March 14, 2025

Hepatic stellate cells control liver function and regeneration

Hepatic stellate cells control liver function and regeneration

Until now, doctors knew hepatic stellate cells mainly as drivers of liver fibrosis. The actual functions of this cell type have hardly been studied to date. Researchers from the German Cancer Research Center (DKFZ), the Mannheim Medical Faculty and Columbia University in New York have now published in the journal Nature that hepatic stellate cells control liver metabolism as well as liver regeneration and size. The results of the study could contribute to new therapeutic approaches for liver diseases.

Hepatic stellate cells control the function of the liver. The different colors show specialized functions of the liver cells within the pentagonal to octagonal liver lobules. Source: Augustin/DKFZ

The liver is a central organ for carbohydrate and protein metabolism as well as for the detoxification of endogenous and exogenous substances. Its vital functions require a high regenerative capacity. Liver cells, so-called hepatocytes, make up about 60 percent of the total cell number of the organ. They have important metabolic tasks and are active in detoxification and metabolism. Endothelial cells provide mass transfer, cholangiocytes transport bile, and Kupffer cells act as a protective barrier.

Hepatic stellate cells are located along the specialized blood capillaries of the liver, known as sinusoids. They are known to drive liver fibrosis, but their actual physiological functions and interactions with other cells are largely uninvestigated.

Scientists led by Hellmut Augustin, DKFZ and the Mannheim Medical Faculty of Heidelberg University, and Robert F. Schwabe, Columbia University, New York, have now shown that stellate cells are essential for liver regeneration and liver metabolism.

Using a genetic trick, the teams led by the two senior authors bred mice whose livers contained no stellate cells. This affected the organ’s detoxification function and its ability to regenerate after injury. The finely balanced architecture of the liver lobules, in which the hepatocytes are arranged according to their different metabolic tasks, was completely disrupted without stellate cells.

The protein Rspondin 3 (RSPO3), which is preferentially produced in stellate cells and regulates the important WNT signaling pathway in liver cells, proved to be a key player in this process. When the researchers specifically switched off RSPO3 in stellate cells, this genetic manipulation had the same effects as the loss of stellate cells.

“The results show that hepatic stellate cells are not only involved in pathological processes, but also play an active role in protecting and regulating liver function,” explains Hellmut Augustin. ”It is particularly noteworthy that the selective silencing of Rspondin 3 leads to similar effects as the removal of the stellate cells themselves – with serious consequences for liver health.”

The researchers also showed that low RSPO3 levels are associated with unfavorable disease progression in patients with alcohol-associated and metabolic liver disease. The new results provide a potential approach for future therapeutic strategies. Instead of focusing solely on inhibiting stellate cells to prevent the development of fibrosis, future treatments could specifically maintain and support their positive, protective functions.

Publication:
Atsushi Sugimoto, Yoshinobu Saito, Guanxiong Wang, Qiuyan Sun,,Chuan Yin, Ki Hong Lee, Yana Geng, Presha Rajbhandari, Celine Hernandez, Marcella Steffani, Jingran Qie, Thomas Savage, Dhruv M. Goyal, Kevin C. Ray, Taruna V. Neelakantan, Deqi Yin, Johannes Melms, Brandon M. Lehrich, Tyler M. Yasaka, Silvia Liu, Michael Oertel, Tian Lan, Adrien Guillot, Moritz Peiseler, Aveline Filliol, Hiroaki Kanzaki, Naoto Fujiwara, Samhita Ravi, Benjamin Izar, Mario Brosch, Jochen Hampe, Helen Remotti, Josepmaria Argemi, Zhaoli Sun, Timothy J. Kendall Yujin Hoshida, Frank Tacke, Jonathan A. Fallowfield, Storm K. Blockley-Powell,Rebecca A. Haeusler, Jonathan B. Steinman, Utpal B. Pajvani, Satdarshan P. Monga,Ramon Bataller, Mojgan Masoodi, Nicholas Arpaia, Youngmin A. Lee, Brent R. Stockwell, Hellmut G. Augustin & Robert F. Schwabe: Hepatic stellate cells control liver zonation, size and functions via Rspondin 3.
Nature 2025, DOI: https://www.nature.com/articles/s41586-025-08677-w 

A picture is available for download:
PM_Augustin_Nature.jpg

Caption: Hepatic stellate cells control the function of the liver. The different colors show specialized functions of the liver cells within the pentagonal to octagonal liver lobules.

Note on use of images related to press releases 
Use is free of charge. The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) permits one-time use in the context of reporting about the topic covered in the press release. Images have to be cited as follows: “Source: Augustin/DKFZ”.
Distribution of images to third parties is not permitted unless prior consent has been obtained from DKFZ’s Press Office (phone: ++49-(0)6221 42 2854, E-mail). Any commercial use is prohibited.

Our latest News

discover more
Frequent blood donations promote the regeneration of blood cells through genetic adaptation

Frequent blood donations promote the regeneration of blood cells through genetic adaptation

Donating blood saves lives – but what long-term effects does this practice have on our bodies? Researchers from the German Cancer Research Center (DKFZ), the HI-STEM stem cell institute* and the German Red Cross Blood Donor Service, among others, have now discovered that frequent blood donations cause genetic adaptations in blood stem cells that promote […]

AGC Biologics Honored for Excellence in Contract Development and Manufacturing

AGC Biologics Honored for Excellence in Contract Development and Manufacturing

Today, we announced that our company won two awards from the annual CDMO Leadership Awards, sponsored by Outsourced Pharma and Life Science Connect. AGC Biologics was named a winner in both the “Biologics – Global” and “Cell & Gene – Global” categories and is one of the few in the industry that scored high enough […]

Celonic Group Leverages Merck’s Breez™ Micro-Bioreactor Platform, Enabling Next-Generation Perfusion-Based Bioprocessing.

Celonic Group Leverages Merck’s Breez™ Micro-Bioreactor Platform, Enabling Next-Generation Perfusion-Based Bioprocessing.

Basel, Switzerland, 12 March 2025 – Celonic Group, a Swiss-Based Quality contract development and manufacturing organization (CDMO), has announced that it is integrating Merck’s Breez™ micro-bioreactor platform into its process development. This addition will further enhance Celonic’s capabilities in monoclonal antibody (mAb) development and manufacturing by enabling highly efficient, scalable perfusion-based bioprocessing from early-stage development to […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp